1. Not So “SMART”
   Steve Nicholson, 2006, Journal of Clinical Oncology CrossRef
2. Consolidation for Ovarian Cancer in Remission
   Paul Sabbatini et al, 2006, Journal of Clinical Oncology CrossRef
3. Brief Overview of Preclinical and Clinical Studies in the Development of Intraperitoneal Radioimmunotherapy for Ovarian Cancer
   Ruby F. Meredith et al, 2007, Clinical Cancer Research CrossRef
4. A brief review of targetted radionuclide therapies
   Mohammed Al-Rowaily et al, 2017, Pakistan Journal of Nuclear Medicine CrossRef
5. B7-H3-targeted Radioimmunotherapy of Human Cancer
   Benjamin B. Kasten et al, 2020, Current Medicinal Chemistry CrossRef
6. MUC1-Targeted Radiopharmaceuticals in Cancer Imaging and Therapy
   Fariba Maleki et al, 2021, Molecular Pharmaceutics CrossRef
7. Efficient Multigram Synthesis of the Bifunctional Chelating Agent (S)-1-p-Isothiocyanatobenzyl-diethylenetetraminepentaacetic Acid
   Donald T. Corson et al, 2000, Bioconjugate Chemistry CrossRef
8. Phase III Trial of Intraperitoneal Therapy With Yttrium-90–Labeled HMFG1 Murine Monoclonal Antibody in Patients With Epithelial Ovarian Cancer After a Surgically Defined Complete Remission
   René H. Verheijen et al, 2006, Journal of Clinical Oncology CrossRef